Risk-Control Strategies: What Auditors Expect but Most Companies Overlook
Risk control is one of the most scrutinised components of a medical device risk management file. While many organisations invest significant effort into hazard identification and risk estimation, auditors consistently report that risk-control strategies lack structure, justification, and evidence. ISO 14971 requires not only the selection of risk controls, but also a defensible hierarchy, objective verification, and clear traceability. This article outlines the expectations auditors bring to risk-control assessment—and the areas where companies frequently fall short.
1. Understanding What Risk Control Must Achieve
A risk-control strategy must:
- Reduce risk as far as reasonably practicable
- Follow the regulatory hierarchy of controls
- Provide objective evidence of implementation and effectiveness
- Remain coherent across design, manufacturing, and post-market processes
Regulators evaluate whether controls are technically robust, justified, verified, and maintained throughout the device lifecycle.
2. The Regulatory Hierarchy of Risk Controls
ISO 14971 establishes a clear priority sequence that auditors expect to see applied:
- Inherent Safety by Design — eliminating the hazard or reducing its likelihood through engineering decisions.
- Protective Measures — alarms, barriers, interlocks, software safeguards, or manufacturing controls.
- Information for Safety — warnings, labels, IFU instructions, and training.
Common audit finding: organisations rely too heavily on warnings rather than addressing hazards through design or protective measures. Auditors expect strong justification whenever a lower-tier control is selected.
3. What Auditors Examine When Reviewing Risk Controls
3.1 Clear Justification for Selected Controls
Auditors expect documented rationale for why each selected control is appropriate. Weaknesses often include:
- No justification for choosing one control method over another
- Risk controls selected based on convenience rather than effectiveness
- Insufficient rationale for relying on information for safety
3.2 Evidence That the Control Was Implemented Correctly
Risk control implementation must be traceably documented. Strong evidence includes:
- Design outputs demonstrating incorporation of the control
- Engineering drawings, specifications, or software requirements
- Manufacturing procedures and validated process parameters
Audit failure example: a risk control listed in the file with no corresponding design requirement or process document.
3.3 Verification of Control Effectiveness
Auditors expect objective evidence proving that each control reduces risk as intended. Verification should include:
- Test reports demonstrating hazard reduction
- Usability studies confirming mitigation of use error
- Software validation results for protective functions
- Process validation confirming capability to maintain control
Failure to link verification activities to specific risk controls is one of the most common audit nonconformities.
3.4 Assessment of Risks Introduced by Controls
ISO 14971 requires evaluating risks that arise because of risk controls themselves. Examples include:
- Software interlocks affecting usability or workflow
- Added components increasing complexity or failure modes
- Labeling changes introducing potential confusion
Auditors frequently highlight missing analysis of secondary risks.
3.5 Completeness and Traceability
Audit-ready risk files exhibit complete traceability across:
- Hazards → hazardous situations → harms
- Risk evaluation → selected controls → verification evidence
- Residual risk → disclosure requirements → IFU content
Any gap or inconsistency in the chain immediately triggers audit escalation.
4. Where Companies Most Commonly Fail
- Over-reliance on warnings instead of design-oriented controls.
- Poor documentation of rationale for selecting specific controls.
- Control measures lacking verification or linked test evidence.
- No evaluation of new risks introduced by the controls implemented.
- Risk controls not reflected in design outputs, manufacturing instructions, or labeling.
- Residual-risk justifications insufficiently supported by clinical or state-of-the-art data.
- Risk controls not maintained across design changes, supplier changes, or production updates.
5. Strengthening Risk-Control Strategies Across the Lifecycle
5.1 Integrate Risk Controls Into Design Inputs
Every risk control should be supported by a corresponding design input. This prevents inconsistencies between the risk file and technical documentation.
5.2 Reflect Risk Controls in Manufacturing Processes
Controls must be represented in:
- Work instructions
- Inspection criteria
- Process validation requirements
Auditors routinely check that production actually maintains the risk reductions claimed in the file.
5.3 Update Risk Controls With Post-Market Evidence
Strong organisations use real-world data to refine controls. This includes:
- Complaint trends
- Service and repair data
- Supplier issues and nonconformities
- CAPA outcomes
5.4 Demonstrate Decision Discipline
Auditors expect evidence that risk-control decisions are made by authorised personnel using defined criteria. Decision discipline establishes confidence in system maturity.
6. What Auditors Consider Indicators of a Mature Risk-Control System
- Clear hierarchy-based selection of controls
- Direct alignment between design documentation and risk files
- Complete verification evidence linked to each control
- Documented analysis of secondary risks
- Continuous updating based on post-market data
- Cross-functional review and approval
Mature systems demonstrate not only compliance, but also technical reasoning and governance discipline—key factors influencing regulatory confidence.
Conclusion
Risk-control strategies reflect the operational and technical maturity of a medical device manufacturer. When controls follow the regulatory hierarchy, are properly justified, thoroughly verified, and continuously maintained, organisations demonstrate the rigor auditors expect. Companies that implement strong, evidence-driven risk controls experience smoother audits, fewer findings, and a more stable product lifecycle.
